Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
- Status
- COMPLETED
- Phase
- PHASE2
CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
- Status
- COMPLETED
- Phase
- NA
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
- Status
- COMPLETED
- Phase
- PHASE3